The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Cross‐match‐compatible platelets can improve corrected count increments (CCIs) in alloimmunised patients with transfusion refractoriness. However, only a few studies mentioned that the specificities of platelet‐reactive alloantibodies can predict high reactivity in cross‐match assays among these patients.
Methods
A total of 204 medical records of patients who were refractory to random...
BackgroundSeveral studies had demonstrated that leucocyte antibodies including anti‐human leucocyte antigen (anti‐HLA) antibodies (class I and class II) and anti‐human neutrophil antigen (anti‐HNA) antibodies (HNA‐1, ‐2 and ‐3) present in the blood products are responsible for transfusion‐related acute lung injury (TRALI). Therefore, selection of blood products exclusive of anti‐HLA and anti‐HNA antibodies...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.